Skip to menu Skip to content Skip to footer
Professor David Mudge
Professor

David Mudge

Email: 

Overview

Background

My current appointment is Director of Kidney Services at Redland Hospitals in Metro South, Brisbane, where I practice as a senior consultant nephrologist.

My research interests are varied and include post-transplant anaemia and iron metabolism, and novel measures of iron status such as hepcidin; improving dialysis outcomes though the implementation of evidence-based guidelines; kidney disease due to thrombotic microangiopathy (particularly aHUS) and the role of inhibitors of the complement system in kidney disease; and the use of honey to prevent infections in dialysis patients.

I am committed to teaching medical students and young nephrologists, and am actively involved in medical education at all levels.

Availability

Professor David Mudge is:
Available for supervision
Media expert

Fields of research

Qualifications

  • Bachelor of Medicine, of Surgery and of Obstetrics, The University of Queensland
  • Doctoral (Research) of Medicine, The University of Queensland

Research impacts

The impact of my research in peritoneal dialysis has been a significant improvement in PD-related infection rates in Australia, which until a few years ago were worse than many other countries in the world. Through a variety of initiatives including a project aiming to improve the use of evidence-based guidelines in clinical practice, we have seen a significant improvement in PD-related infections (particularly peritonitis but also exit-site infections), one of the most significant contributors to peritoneal dialysis technique failure.

In kidney transplantation my research has helped to clarify the role of immune suppressing medications on iron availability and anaemia and has looked at novel ways of measuring iron status in patients with kidney disease as well as better ways of enhancing iron stores in these patients.

Works

Search Professor David Mudge’s works on UQ eSpace

145 works between 2000 and 2024

141 - 145 of 145 works

2004

Journal Article

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

Atcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033

Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection

2004

Journal Article

A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement

Johnson, David W., Mudge, David W., Blizzard, Sophie, Arndt, Mary, O'Shea, Amanda, Watt, Rhonda, Hamilton, Jan, Cottingham, Sharon, Isbel, Nicole M. and Hawley, Carmel M. (2004). A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement. Peritoneal Dialysis International, 24 (5), 460-465. doi: 10.1177/089686080402400511

A comparison of peritoneal equilibration tests performed 1 and 4 weeks after PD commencement

2004

Conference Publication

Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantation

Tett, S. E., Atcheson, B. A., Taylor, P. J., Johnson, D. W., Mudge, D. W. and Pillans, P. I. (2004). Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantation. 8th World Conference on Clinical Pharmacology & Therapeutics 2004, Brisbane, Australia, 1-6 August, 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x

Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantation

2003

Journal Article

Predictors of decline of residual renal function in new peritoneal dialysis patients

Johnson, David W., Mudge, David W., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M. and Hollett, Peter (2003). Predictors of decline of residual renal function in new peritoneal dialysis patients. Peritoneal Dialysis International, 23 (3), 276-283.

Predictors of decline of residual renal function in new peritoneal dialysis patients

2000

Journal Article

Paracetamol and asthma

Mudge, D. (2000). Paracetamol and asthma. Thorax, 55 (10), 882-882.

Paracetamol and asthma

Funding

Past funding

  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant

Supervision

Availability

Professor David Mudge is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Professor David Mudge directly for media enquiries about:

  • Anaemia
  • Chronic kidney disease
  • Iron regulation
  • Kidney disease
  • Kidney transplantation
  • Organ transplant - kidney
  • Transplant - kidney

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au